Icaritin (Flavonoid)

Icaritin is a prenylflavonoid derivative of icariin that demonstrates potent anti-cancer activity through cell cycle arrest and apoptosis induction. This bioactive compound primarily targets hepatocellular carcinoma cells with IC50 values ranging from 3-8 μM in preclinical studies.

Origin & History

Icaritin is a prenylated flavonoid aglycone found in plants of the genus Epimedium (horny goat weed), serving as the deglycosylated form of icariin. It is produced naturally in low amounts or via enzymatic hydrolysis using Aspergillus sp. flavonoid-glycosidase, yielding 92.5% molar purity at 98% HPLC purity through biotransformation.

Historical & Cultural Context

Icaritin occurs in Epimedium herbs used in Traditional Chinese Medicine. However, no specific historical context or traditional indications for icaritin itself (versus glycosides like icariin) are documented in available sources.

Health Benefits

• Anti-cancer effects: Preclinical studies show icaritin inhibits hepatocellular carcinoma cell lines (HepG2, SMMC-7721) with IC50 values of 3-8 μM (evidence quality: preliminary)
• Cell cycle regulation: Induces G0/G1 arrest in cancer cells, promoting apoptosis (evidence quality: preliminary)
• Multi-organ support: Preclinical data suggests potential benefits for liver, lung, heart, bone, blood, skin, and immunity (evidence quality: preliminary)
• Enhanced potency derivatives: Structural modifications at OH-3 and OH-7 sites show improved anticancer activity (evidence quality: preliminary)
• Flavonoid antioxidant properties: As a flavonoid compound, may offer antioxidant benefits (evidence quality: theoretical based on chemical structure)

How It Works

Icaritin induces G0/G1 phase cell cycle arrest by modulating cyclin-dependent kinase pathways and promoting p53-mediated apoptosis. The compound activates caspase cascades while downregulating anti-apoptotic proteins like Bcl-2. It also demonstrates estrogen receptor modulation and potential anti-angiogenic effects through VEGF pathway inhibition.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on icaritin were identified. Research is limited to preclinical in vitro studies, such as anti-hepatocellular carcinoma effects where icaritin derivatives inhibited Hep3B, HepG2, and SMMC-7721 cell lines, with derivative 11c showing IC50 values of 7.6 μM (HepG2) and 3.1 μM (SMMC-7721).

Clinical Summary

Current evidence for icaritin is limited to preclinical in vitro and animal studies, with no completed human clinical trials. Laboratory studies demonstrate cytotoxicity against hepatocellular carcinoma cell lines (HepG2, SMMC-7721) with IC50 values of 3-8 μM. Animal studies suggest potential hepatoprotective and anti-tumor effects, but effective human dosing remains undetermined. The evidence quality is preliminary and requires human clinical validation.

Nutritional Profile

{"bioactive_compounds": {"icaritin": {"concentration": "variable", "bioavailability_notes": "Limited human data; bioavailability may be affected by metabolism and absorption rates."}}, "macronutrients": {"protein": "Not applicable", "fiber": "Not applicable"}, "micronutrients": {"vitamins": "Not applicable", "minerals": "Not applicable"}}

Preparation & Dosage

No clinically studied dosage ranges for icaritin in humans are available. In vitro anticancer assays used icaritin concentrations yielding IC50 values around 3-8 μM against HCC cells, but no standardization or human dosing has been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Icariin, Epimedin A, Epimedin B, Epimedin C, Other Epimedium flavonoids

Safety & Interactions

Safety data for icaritin in humans is extremely limited due to lack of clinical trials. As a flavonoid derivative, it may interact with cytochrome P450 enzymes, potentially affecting drug metabolism. Theoretical concerns include hormonal effects due to estrogen receptor activity, making it potentially unsuitable during pregnancy and breastfeeding. Individuals on anticoagulant medications should exercise caution due to potential bleeding risk associated with flavonoid compounds.